作者：
Alberto,Ballestrero [1]
;
Davide,Bedognetti [2]
;
Domenico,Ferraioli [3]
;
Paola,Franceschelli [2]
;
Sana Intidhar,Labidi-Galy [4]
;
Elisabetta,Leo [2]
;
Junko,Murai [5]
;
Yves,Pommier [6]
;
Petros,Tsantoulis [7]
;
Valerio Gaetano,Vellone [7]
;
Gabriele,Zoppoli [5]
作者单位：
Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Martino IST-Istituto Nazionale Tumori, Genoa, Italy.
[1]
Università degli Studi di Genova, Viale Benedetto XV, 6, 16132, Genoa, Italy.
[2]
Tumor Biology Immunology and Therapy Branch, Sidra Medical and Research Center, Doah, Qatar.
[3]
Centre de Lutte contre le Cancer Léon Bérard, Lyon, France.
[4]
Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
[5]
Oncology, Innovative Medicine Early Development, AstraZeneca, Cambridge, UK.
[6]
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[7]
Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Martino IST-Istituto Nazionale Tumori, Genoa, Italy. gabriele.zoppoli@unige.it.
[8]
Università degli Studi di Genova, Viale Benedetto XV, 6, 16132, Genoa, Italy. gabriele.zoppoli@unige.it.
[9]
DOI
10.1186/s12967-017-1296-3
PMID
28969705
发布时间
2018-12-02
换一批
换一批
